2011
DOI: 10.1016/j.exppara.2011.09.013
|View full text |Cite
|
Sign up to set email alerts
|

A recombinant thioredoxin-glutathione reductase from Fasciola hepatica induces a protective response in rabbits

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
9
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(9 citation statements)
references
References 37 publications
0
9
0
Order By: Relevance
“…The construct for recombinant expression of E. granulosus TGR was previously generated [15].The construct for F. hepatica TGR was generated using the same methodology [18]. Both TGR constructs contained the Sec insertion sequence (SECIS) element of E. coli formate dehydrogenase H at a 10 nucleotide distance from the penultimate UGA Sec codon, to allow stop codon recoding to Sec, as previously described [15], [18].…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…The construct for recombinant expression of E. granulosus TGR was previously generated [15].The construct for F. hepatica TGR was generated using the same methodology [18]. Both TGR constructs contained the Sec insertion sequence (SECIS) element of E. coli formate dehydrogenase H at a 10 nucleotide distance from the penultimate UGA Sec codon, to allow stop codon recoding to Sec, as previously described [15], [18].…”
Section: Methodsmentioning
confidence: 99%
“…Both TGR constructs contained the Sec insertion sequence (SECIS) element of E. coli formate dehydrogenase H at a 10 nucleotide distance from the penultimate UGA Sec codon, to allow stop codon recoding to Sec, as previously described [15], [18]. For recombinant protein expression, TGR constructs were used to transform E. coli BL21(DE3) cells previously transformed with pSUABC, a plasmid that encodes selA , selB and selC , supporting high level expression of the genes involved in Sec incorporation [19].…”
Section: Methodsmentioning
confidence: 99%
“…Over the last decade a large number of native and recombinant parasite proteins have been identified and tested as vaccine in a number of animals models. Some of these molecules includes leucinaminopeptidase (Maggioli et al, 2011a), cathepsin-L (Chantree et al, 2013; Golden et al, 2010; Piacenza et al, 1999), thioredoxin-glutathion reductase (Maggioli et al, 2011b), glutathione S-transferase (Sexton et al, 1990; Sexton et al, 1994), fatty acid binding protein (Casanueva et al, 2001; Martinez-Fernandez et al, 2004) and saposin-like protein-2 (Espino et al, 2010; Kueakhai et al, 2013). All these vaccine candidates have induced partial levels of protection that range between 46.9–83% in different animal models, which indicates that a vaccine against F. hepatica is not a chimera but an attainable goal.…”
Section: Introductionmentioning
confidence: 99%
“…Several different types of acidic/neutral cytosolic-, μ-, σ- and ω-class GSTs have been characterized in helminth parasites [17]. Most helminth GSTs are expressed in the parasite's parenchyme and subteguments, which suggests either that they interact with physiologically/pathologically active molecules during the phase II detoxification process, or that these enzymes are secreted and directly contact the host's defensive system [18]. Crystal structure and molecular modeling studies have revealed critical differences in their substrate and/or inhibitor specificity according to xenobiotic substrate-binding sites [19], [20], which implies that these isozymes might mediate different cellular homeostatic processes.…”
Section: Introductionmentioning
confidence: 99%